Cosic I., Baldi E., Grace R.J., Heath B, Cohen M., Lithgow B., 1999, Muscle Tissue Recovery Using the Low-frequency Electromagnetic Field, Medical & Biological Engineering & Computing, 37, Supp.2, (Proc. EMBES’99 – European Medical & Biological Engineering Conference, Vienna, Austria,) 1334-1335.
N/A
Baldi, E., Lithgow, B., Heath, B., Cohen M.,, Cosic, I., Grace, R.J. 1999, A pilot study on the extremely low frequency (ELF) pulsing magnetic field (PMF) effect on soft tissue injuries: A preliminary analysis of results. Medical & Biological Engineering & Computing, 37, Suppl 1, 103-104.
N/A
Lithgow B., Heath B., Baldi E., Cohen M., Cosic I., Grace R. J., (1999), “Extremely Low Frequency (ELF) Pulsing Magnetic Field (PMF) Effects on Soft Tissues Injuries”, IEEE EMBS, 21, Vol. 2, 1295.
N/A
Bonello, R.P., Cohen, M., Reece, J., Aggarwal, A., Rigney, C., (2014) A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy, Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 341256, 6 pages, 2014. doi:10.1155/2014/341256
The Electro-Neuro-Adaptive-Regulator (ENAR) device is a hand-held electrotherapy which is applied using energetic medicine principles and aspects of acupuncture theory. The aim of this paper is to report the findings of a postmarket survey of persons who have used the ENAR device. The conditions for which the therapy was used and its perceived effectiveness are discussed. A web-based survey of Australian recipients of ENAR therapy was completed by 481 respondents. Most (76%) used ENAR exclusively for pain relief for musculoskeletal disorders, especially back, shoulder, and neck pain; 8% used ENAR exclusively for nonmusculoskeletal disorders; while 16% used ENAR for both. Respondents reported a mean reduction in pain of 70% (t(423) = 38.73, P < .001) and functional improvement of 62% (t(423) = 10.45, P < .001) using 11-point numerical rating scales. Following ENAR treatment, medication reduction was reported by 91% of respondents. Most respondents reported high satisfaction following ENAR therapy, with between 15 and 20% achieving complete pain relief. The self-delivery of ENAR may, in part, account for the high level of satisfaction.